GRAL

GRAIL Inc · NASDAQ

Sector Health Technology
Industry Medical Specialties
Website grail.com
Employees(FY) -
ISIN US3847471014

Performance

-0.0%

+2.24%

-10.13%

+10.47%

YTD

+10.47%

Profile

GRAIL, LLC, a biotechnology company, focuses on developing technologies for early cancer detection. The company develops Galleri, a screening test for asymptomatic individuals over 50 years of age; and DAC, a diagnostic aid for cancer tests to accelerate diagnostic resolution for patients for whom there is a clinical suspicion of cancer. It is also developing minimal residual disease and other post-diagnostic tests. GRAIL, LLC was formerly known as PSC15, Inc. and changed its name to GRAIL, LLC in January 2016. The company was incorporated in 2015 and is based in Menlo Park, California. GRAIL, LLC operates as a subsidiary of Illumina, Inc.

Advanced Technical Analysis

Stock Analysis of GRAL

Stock Rank

Recent News & Updates

2024-11-19 16:23
Grail Insider Sold Shares Worth $426,937, According to a Recent SEC Filing(MT Newswires)
2024-11-19 16:05
GRAIL to Participate in Upcoming Investor Conferences(PR Newswire)
2024-11-19 03:05
GRAIL to Participate in Upcoming Investor Conferences(Prnewswire)
2024-11-18 17:10
GRAIL Says First Person Tested With Blood-Based Assay in Lung Cancer Trial(MT Newswires)
2024-11-18 16:01
GRAIL Announces First Patient Tested With Blood-Based Assay in Global Phase 3 Adjuvant Lung Cancer Study(PR Newswire)
2024-11-18 03:01
GRAIL Announces First Patient Tested With Blood-Based Assay in Global Phase 3 Adjuvant Lung Cancer Study(Prnewswire)
2024-11-17 20:16
Is Illumina, Inc. (ILMN) the Best Immunotherapy Stock to Buy Now?(Yahoo Finance)
2024-11-14 14:00
GRAIL Inc (GRAL) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Amidst Strategic ...(GuruFocus.com)
2024-11-14 05:13
GRAIL Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag(Simply Wall St.)
2024-11-12 16:06
GRAIL Reports Third Quarter 2024 Financial Results(PR Newswire)
2024-11-12 03:06
GRAIL Reports Third Quarter 2024 Financial Results(Prnewswire)
2024-11-04 16:01
GRAIL to Present at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum(PR Newswire)
2024-11-04 03:01
GRAIL to Present at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum(Prnewswire)
2024-10-29 16:01
GRAIL to Announce Third Quarter 2024 Financial Results(PR Newswire)
2024-10-29 04:01
GRAIL to Announce Third Quarter 2024 Financial Results(Prnewswire)
2024-10-23 18:00
GRAIL Presents Initial Results From REFLECTION Real-World Evidence Study of Galleri速 Multi-Cancer Early Detection (MCED) Test at the Early Detection of Cancer Conference(PR Newswire)
2024-10-23 06:00
GRAIL Presents Initial Results From REFLECTION Real-World Evidence Study of Galleri Multi-Cancer Early Detection (MCED) Test at the Early Detection of Cancer Conference(Prnewswire)
2024-10-21 16:01
GRAIL Appoints Sarah Krevans to Board of Directors(PR Newswire)
2024-10-21 04:01
GRAIL Appoints Sarah Krevans to Board of Directors(Prnewswire)
2024-10-15 14:00
Essential Pharma Announces the Appointment of Dr Liz Holmes as Chief Medical Officer(Globenewswire)
2024-10-13 16:59
GRAIL, Inc. (GRAL): Jeff Bezos Is Buying This Stock Now(Insider Monkey)
2024-10-13 04:59
GRAIL, Inc. (GRAL): Jeff Bezos Is Buying This Stock Now(Insidermonkey)
2024-09-30 09:04
CRCM LP's Strategic Acquisition of GRAIL Inc Shares(Yahoo Finance)
2024-09-02 23:37
Illumina Wins Court Fight With EU Over $7 Billion Grail Deal(Yahoo Finance)
2024-08-30 05:55
GRAIL ANNOUNCES INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(c)(4)(Prnewswire)
2024-08-29 16:16
Results of GRAIL's Galleri速 Multi-Cancer Early Detection Blood Test in Prostate Cancer Published in JCO Precision Oncology(PR Newswire)
2024-08-29 04:16
Results of GRAIL's Galleri Multi-Cancer Early Detection Blood Test in Prostate Cancer Published in JCO Precision Oncology(Prnewswire)
2024-08-22 16:11
Grail Insider Sold Shares Worth $1,203,650, According to a Recent SEC Filing(MT Newswires)
2024-08-22 16:10
Grail Insider Sold Shares Worth $254,121, According to a Recent SEC Filing(MT Newswires)
2024-08-21 16:01
GRAIL to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference(PR Newswire)

Page 1 of 2

previousnext

Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment. Kavout and its partners are participants in a number of affiliate advertising programs. As an Amazon Associate, Kavout or its partners earn from qualifying purchases from affiliate links. We also participate in other affiliate and advertising programs that provide a means for us to earn advertising fees by advertising and linking to third-party websites.